Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The prostate‐specific phosphatase and tensin homolog deleted on chromosome 10 (<i>Pten)</i> gene‐conditional knockout (KO) mouse carcinogenesis model is highly desirable for studies of prostate cancer biology and chemoprevention due to its close resemblance of primary molecular defect and many histopathological features of human prostate cancer including androgen response and disease progression from prostatic intraepithelial neoplasia to invasive adenocarcinoma. Here, we profiled the proteome and transcriptome of the <i>Pten</i>‐KO mouse prostate tumors for global macromolecular expression alterations for signaling changes and biomarker signatures. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>For proteomics, four pairs of whole prostates from tissue‐specific conditional knockout <i>Pten</i>‐KO mice (12‐15 weeks of age) and their respective wild‐type littermates housed in the same cages were analyzed by 8‐plex isobaric tags for relative and absolute quantitation iTRAQ. For microarray transcriptomic analysis, three additional matched pairs of prostate/tumor specimens from respective mice at 20 to 22 weeks of age were used. Real‐time quantitative reverse transcription‐polymerase chain reaction was used to verify the trends of protein and RNA expression changes. Gene Set Enrichment Analysis and Ingenuity Pathway Analysis were carried out for bioinformatic characterizations of pathways and networks. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>At the macromolecular level, proteomic and transcriptomic analyses complement and cross‐validate to reveal overexpression signatures including inflammation and immune alterations, in particular, neutrophil/myeloid lineage suppressor cell features, chromatin/histones, ion and nutrient transporters, and select glutathione peroxidases and transferases in <i>Pten</i>‐KO prostate tumors. Suppressed expression patterns in the <i>Pten</i>‐KO prostate tumors included glandular differentiation such as secretory proteins and androgen receptor targets, smooth muscle features, and endoplasmic reticulum stress proteins. Bioinformatic analyses identified <i>immune and inflammation responses</i> as the most profound macromolecular landscape changes, and the predicted key nodal activities through Akt, nuclear factor‐kappaB, and P53 in the <i>Pten</i>‐KO prostate tumor. Comparison with other genetically modified mouse prostate carcinogenesis models revealed notable molecular distinctions, especially the dominance of <i>immune and inflammation features</i> in the <i>Pten</i>‐KO prostate tumors. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our work identified prominent macromolecular signatures and key nodal molecules that help to illuminate the patho‐ and immunobiology of <i>Pten</i>‐loss driven prostate cancer and can facilitate the choice of biomarkers for chemoprevention and interception studies in this clinically relevant mouse prostate cancer model. </p></section>

Expression Profiling of the Mouse Prostate after Castration and Hormone Replacement: Implication of H-cadherin in Prostate Tumorigenesis.

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates Δ-Catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis

Prostate-Specific Deletion of Cdh1 Induces Murine Prostatic Inflammation and Bladder Overactivity

Probasin Promoter-Driven Expression of ID1 is Not Sufficient for Carcinogenesis in Rodent Prostate.

Anti-androgen Therapy Induces Transcriptomic Reprogramming in Metastatic Castration-Resistant Prostate Cancer in a Murine Model.

Notch1-expressing Cells Are Indispensable for Prostatic Branching Morphogenesis During Development and Re-growth Following Castration and Androgen Replacement*

Bulk mRNA-seq data from wild-type and prostate cancer-developing mice reveal a reprogramming of the estrogen and androgen responses after carcinogenesis

Data from Inactivation of <i>apc</i> in the Mouse Prostate Causes Prostate Carcinoma

Conserved gene expression programs integrate mammalian prostate development and tumorigenesis

Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression

Comparative RNA-sequencing Analysis of the Prostate in a Mouse Model of Benign Prostatic Hyperplasia with Bladder Outlet Obstruction.

Altered Differentiation and Proliferation of Prostate Epithelium in Mice Lacking the Androgen Receptor Cofactor P44/wdr77.

Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis

Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer

A Human- And Male-Specific Protocadherin That Acts Through The Wnt Signaling Pathway To Induce Neuroendocrine Transdifferentiation Of Prostate Cancer Cells

Cdna Microarray Analysis of Transgenic and Knock-in Prostate Cancer Mouse Models

Differentiation of the Ductal Epithelium and Smooth Muscle in the Prostate Gland Are Regulated by the Notch/PTEN-dependent Mechanism

Dynamics of Notch Expression During Murine Prostate Development and Tumorigenesis